needed demonstrate drug effectiveness study involved small numbers patients early consider berzosertib game changer cancer treatment said dr darius widera university reading unusually strong effects berzosertib especially combination conventional chemotherapy reasons optimistic outcomes follow studies philip malling 62 year old diagnosed bowel cancer 2012 enrolled trial years unsuccessful chemotherapy told said april 2014 told probably dead christmas receiving berzosertib treatment years tumors shrunk condition stable means mr malling told bbc patient ovarian cancer returned following different course treatment saw tumors shrink combination treatment drug chemotherapy chemotherapy works damaging cancer cells dna conjunction new treatment stops cells repairing appears greater benefit